Latest Stories
Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers
Dogster
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans
Biopharma Boardroom
From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology
Pharmacy Times
New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma
American Animal Hospital Association NEWStat®
Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences
Veterinary Practice
Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma
DVM360
ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market
Pulse 2.0
New AI service offers personalized drug response predictions for canine patients with cancer
DVM360
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
TechCrunch
Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How
Innovative Veterinary Care Journal
How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue
Innovative Veterinary Care Journal
ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys
Innovative Veterinary Care Journal